The FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related semaglutide-based drugs, Ozempic and Wegovy – since 2022 amid unprecedented demand.

KVIA

Panama City

Bay County

Florida

United States

The end of a shortage of popular weight-loss drugs may mean many people lose access to them

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a shortage of the brand-name drug has ended – which means compounding of the medicine must stop.

Ad Fontes Media

All Sides

Media Bias/Fact Check

Warner Bros. Discovery

Atlanta

Fulton County

Georgia

By Meg Tirrell, CNN (CNN) — If there’s a diet, Janet McCaskill says, she’s done it. “I’ve tried WeightWatchers. I’ve tried keto. I’ve gone to a nutritionist,” said the 58-year-old grandmother, who lives in Knightdale, North Carolina, outside Raleigh. Some of the eating plans worked, she said – until they didn’t. At the end of 2022, weighing about 212 pounds and fearful about her health after losing her brother and both parents to heart disease, …

News-Press & Gazette Company

KCRA 3

Hearst Communications

Sacramento

Sacramento County

California

WLWT

Cincinnati

Hamilton County

Ohio

WMUR

New Hampshire

WESH

Koco News5

KETV

Omaha

Douglas County

Nebraska

WYFF

Greenville

Greenville County

South Carolina

WTAE

Pittsburgh

Allegheny County

Pennsylvania

Diabetes

Ozempic

Diet

WBAL-TV

WPTZ

WMTW

WAPT

KOAT

WGAL

East Idaho News

KSBW

WJCL

KHBS

MOR-TV

The end of a shortage of popular weight-loss drugs may mean many people lose access to them

Coverage Details

Give the gift of Perspective

Bias Distribution

Ownership

Similar News Topics

Similar News Topics